Lumexa Imaging Inc. Common Stock
LMRI | NASDAQ
$11.39
-$0.02 (-0.18%)
Nov 2, 2026, 9:57 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 |
|---|---|---|---|---|---|---|
Revenue | 264.16M | 252.54M | 267.73M | 258.94M | 245M | 248.03M |
Cost of Revenue | 235.37M | 227.68M | 238.01M | 219.24M | 208.4M | 226.46M |
Gross Profit | 28.79M | 24.86M | 29.72M | 39.71M | 36.6M | 21.57M |
Operating Income | 4.4M | 4.53M | -7.47M | 12.97M | 10.06M | 15.25M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 5.77M | 3.08M | -25.26M | -237K | -4.31M | -16.03M |
Net Income | 2.75M | 1.72M | -28.69M | -3.5M | -7.69M | -25.06M |
Selling & General & Admin | 24.4M | 20.34M | 37.19M | 17.08M | 17.49M | 20.12M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | n/a | n/a | 9.65M | 9.05M | -13.8M |
Operating Expenses | 24.4M | 20.34M | 37.19M | 26.74M | 26.54M | 6.32M |
Interest Expense | 16.22M | 16.33M | 28.02M | 30.58M | 29.85M | 31.39M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 259.77M | 248.01M | 275.2M | 245.97M | 234.94M | 232.78M |
Income Tax Expense | 3.02M | 1.36M | 3.43M | 3.26M | 3.38M | 9.03M |
Shares Outstanding (Basic) | 95.98M | 95.98M | 75.35M | 82.77M | 94.57M | 94.57M |
Shares Outstanding (Diluted) | 96.01M | 95.98M | 75.35M | 82.77M | 94.57M | 94.57M |
EPS (Basic) | 0.03 | 0.02 | -0.38 | -0.04 | -0.08 | -0.26 |
EPS (Diluted) | 0.03 | 0.02 | -0.38 | -0.04 | -0.08 | -0.26 |
EBITDA | 19.08M | 33.45M | 15.15M | 43.73M | 38.33M | 28.94M |
EBIT | 4.4M | 19.41M | 2.76M | 30.34M | 25.54M | 15.36M |
Depreciation & Amortization | 14.68M | 14.04M | 12.4M | 13.39M | 12.79M | 13.58M |
Add to Watchlist
Select watchlists to add or remove LMRI